Preparation and Characterization of (-)-Epigallocatechin-3-gallate (EGCG)-loaded Nanoparticles and Their Inhibitory Effects on Human Breast Cancer MCF-7 Cells

Overview

Journal Sci Rep

Specialty Science

Date 2017 Mar 29

PMID 28349962

Citations 28

Authors

Liang Zeng

Jingna Yan

Liyong Luo

Mengjun Ma

Huiqun Zhu

Affiliations

Soon will be listed here.

Abstract

We were employing nanotechnology to improve the targeting ability of (-)-Epigallocatechin-3-gallate (EGCG) towards MCF-7 cells, and two kinds of EGCG nanoparticles (FA-NPS-PEG and FA-PEG-NPS) were obtained, besides, their characteristics and effects on MCF-7 cells were studied. The results indicated that (i) both FA-NPS-PEG and FA-PEG-NPS have high stabilities; (ii) their particles sizes were 185.0 ± 13.5 nm and 142.7 ± 7.2 nm, respectively; (iii) their encapsulation efficiencies of EGCG were 90.36 ± 2.20% and 39.79 ± 7.54%, respectively. (iv) there was no cytotoxicity observed in EGCG, FA-NPS-PEG and FA-PEG-NPS toward MCF-7 cells over all concentrations (0~400 μg/mL) tested; (v) EGCG, FA-NPS-PEG and FA-PEG-NPS inhibited MCF-7 cells proliferation in dose-dependent manners, with the average IC of 470.5 ± 33.0, 65.9 ± 0.4 and 66.6 ± 0.6 μg/mL; (vi) EGCG, FA-NPS-PEG and FA-PEG-NPS could modulated the expressions of several key regulatory proteins in PI3K-Akt pathway such as up-regulation of PTEN, p21 and Bax, and down-regulation of p-PDK1, p-AKT, CyclinD1 and Bcl-2, which gave an illustration about the mechanism by which EGCG nanoparticles inhibited MCF-7 cells proliferation. In this study, EGCG nanoparticles can significantly enhance the targeting ability and efficacy of EGCG, which is considered to an experimental foundation for further research on its activity, targeting ability and metabolism in vivo.

Citing Articles

Green Tea: Current Knowledge and Issues.

Radeva-Ilieva M, Stoeva S, Hvarchanova N, Georgiev K Foods. 2025; 14(5).

PMID: 40077449 PMC: 11899301. DOI: 10.3390/foods14050745.

Role of Epigallocatechin Gallate in Selected Malignant Neoplasms in Women.

Markowska A, Antoszczak M, Markowska J, Huczynski A Nutrients. 2025; 17(2).

PMID: 39861342 PMC: 11767294. DOI: 10.3390/nu17020212.

Development of Epigallocatechin and Ascorbic Acid Dual Delivery Transferosomes for Managing Alzheimer's Disease: In Vitro and in Vivo Studies.

Mishra G, Awasthi R, Mishra S, Singh A, Tiwari A, Singh S ACS Omega. 2024; 9(33):35463-35474.

PMID: 39184506 PMC: 11339821. DOI: 10.1021/acsomega.4c02140.

Feasibility Study of Developing a Saline-Based Antiviral Nanoformulation Containing Lipid-Soluble EGCG: A Potential Nasal Drug to Treat Long COVID.

Frank N, Dickinson D, Garcia W, Liu Y, Yu H, Cai J Viruses. 2024; 16(2).

PMID: 38399972 PMC: 10891529. DOI: 10.3390/v16020196.

Induction of Apoptosis and Modulation of Caspase Activity on MCF-7 Human Breast Cancer Cells by Bioactive Fractionated Cocoa Leaf Extract.

Ranneh Y, Abu Bakar M, Md Akim A, Bin Baharum Z, S Ellulu M, Fadel A Asian Pac J Cancer Prev. 2023; 24(7):2473-2483.

PMID: 37505782 PMC: 10676477. DOI: 10.31557/APJCP.2023.24.7.2473.

References

Chehrehasa F, Meedeniya A, Dwyer P, Abrahamsen G, Mackay-Sim A . EdU, a new thymidine analogue for labelling proliferating cells in the nervous system. J Neurosci Methods. 2008; 177(1):122-30. DOI: 10.1016/j.jneumeth.2008.10.006. View

Gan Q, Wang T, Cochrane C, McCarron P . Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids Surf B Biointerfaces. 2005; 44(2-3):65-73. DOI: 10.1016/j.colsurfb.2005.06.001. View

Levine D, Bogomolniy F, Yee C, Lash A, Barakat R, Borgen P . Frequent mutation of the PIK3CA gene in ovarian and breast cancers. Clin Cancer Res. 2005; 11(8):2875-8. DOI: 10.1158/1078-0432.CCR-04-2142. View

Liang Y, Lin-Shiau S, Chen C, Lin J . Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate. J Cell Biochem. 1999; 75(1):1-12. View

Mereles D, Hunstein W . Epigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises?. Int J Mol Sci. 2011; 12(9):5592-603. PMC: 3189735. DOI: 10.3390/ijms12095592. View

Klein R, Fischer S . Black tea polyphenols inhibit IGF-I-induced signaling through Akt in normal prostate epithelial cells and Du145 prostate carcinoma cells. Carcinogenesis. 2002; 23(1):217-21. DOI: 10.1093/carcin/23.1.217. View

Yeh C, Chen W, Chiang C, Lin-Shiau S, Lin J . Suppression of fatty acid synthase in MCF-7 breast cancer cells by tea and tea polyphenols: a possible mechanism for their hypolipidemic effects. Pharmacogenomics J. 2003; 3(5):267-76. DOI: 10.1038/sj.tpj.6500192. View

Sudimack J, Lee R . Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev. 2000; 41(2):147-62. DOI: 10.1016/s0169-409x(99)00062-9. View

Sun J, Liu R . Cranberry phytochemical extracts induce cell cycle arrest and apoptosis in human MCF-7 breast cancer cells. Cancer Lett. 2005; 241(1):124-34. DOI: 10.1016/j.canlet.2005.10.027. View

10.

Zeng C, Pan F, Jones L, Lim M, Griffin E, Sheline Y . Evaluation of 5-ethynyl-2'-deoxyuridine staining as a sensitive and reliable method for studying cell proliferation in the adult nervous system. Brain Res. 2010; 1319:21-32. PMC: 2826567. DOI: 10.1016/j.brainres.2009.12.092. View

11.

Kim S, Um J, Kwon B, Kim D, Chung B, Kang C . Potentiation of chemosensitivity in multidrug-resistant human leukemia CEM cells by inhibition of DNA-dependent protein kinase using wortmannin. Leuk Res. 2000; 24(11):917-25. DOI: 10.1016/s0145-2126(00)00061-8. View

12.

Qin J, Xie L, Zheng X, Wang Y, Bai Y, Shen H . A component of green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins. Biochem Biophys Res Commun. 2007; 354(4):852-7. DOI: 10.1016/j.bbrc.2007.01.003. View

13.

Liu R . Health-promoting components of fruits and vegetables in the diet. Adv Nutr. 2013; 4(3):384S-92S. PMC: 3650511. DOI: 10.3945/an.112.003517. View

14.

Yang C, Wang X, Lu G, Picinich S . Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer. 2009; 9(6):429-39. PMC: 2829848. DOI: 10.1038/nrc2641. View

15.

Hosseinkhani H, Tabata Y . PEGylation enhances tumor targeting of plasmid DNA by an artificial cationized protein with repeated RGD sequences, Pronectin. J Control Release. 2004; 97(1):157-71. DOI: 10.1016/j.jconrel.2004.02.025. View

16.

Chinni S, Sarkar F . Akt inactivation is a key event in indole-3-carbinol-induced apoptosis in PC-3 cells. Clin Cancer Res. 2002; 8(4):1228-36. View

17.

Varticovski L, Lu Z, Mitchell K, de Aos I, Kopecek J . Water-soluble HPMA copolymer-wortmannin conjugate retains phosphoinositide 3-kinase inhibitory activity in vitro and in vivo. J Control Release. 2001; 74(1-3):275-81. DOI: 10.1016/s0168-3659(01)00349-2. View

18.

Hsieh T, Wu J . Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and gamma-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells. Int J Oncol. 2008; 33(4):851-9. View

19.

Lecumberri E, Dupertuis Y, Miralbell R, Pichard C . Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy. Clin Nutr. 2013; 32(6):894-903. DOI: 10.1016/j.clnu.2013.03.008. View

20.

Pianetti S, Guo S, Kavanagh K, Sonenshein G . Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells. Cancer Res. 2002; 62(3):652-5. View